Todd W Bauer Selected Research

Cholangitis

7/2015	IgG4-Associated Cholangitis Can Mimic Hilar Cholangiocarcinoma.
11/2014	ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Todd W Bauer Research Topics

Disease

68	Neoplasms (Cancer) 03/2024 - 08/2002
29	Cholangiocarcinoma 02/2024 - 11/2014
23	Pancreatic Neoplasms (Pancreatic Cancer) 03/2024 - 07/2005
18	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2005
8	Adenocarcinoma 03/2024 - 01/2011
5	Infections 01/2018 - 05/2005
4	Lymphatic Metastasis 03/2023 - 12/2018
4	Colorectal Neoplasms (Colorectal Cancer) 02/2013 - 04/2005
4	Carcinoma (Carcinomatosis) 11/2007 - 01/2005
2	Margins of Excision 03/2024 - 01/2024
2	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 02/2019
2	Heart Arrest (Cardiac Arrest) 11/2018 - 01/2016
2	Sepsis (Septicemia) 11/2018 - 06/2015
2	Malnutrition (Nutritional Deficiencies) 11/2018 - 01/2016
2	Embolism (Embolus) 11/2018 - 01/2016
2	Liver Neoplasms (Liver Cancer) 10/2018 - 11/2016
2	Klatskin Tumor 01/2018 - 10/2012
2	Neoplasm Micrometastasis 01/2018 - 01/2016
2	Pancreatic Fistula (Pancreatic Fistulas) 01/2018 - 05/2011
2	Breast Neoplasms (Breast Cancer) 01/2016 - 03/2002
2	Cholangitis 07/2015 - 11/2014
2	Melanoma (Melanoma, Malignant) 04/2003 - 08/2002
1	Hypoxia (Hypoxemia) 03/2024
1	Inflammation (Inflammations) 01/2024
1	Confusion (Bewilderment) 07/2023
1	Postoperative Pain 11/2022

Drug/Important Bio-Agent (IBA)

7	Gemcitabine FDA Link 07/2023 - 09/2005
6	AntigensIBA 03/2024 - 01/2018
5	CarbohydratesIBA 03/2024 - 01/2018
4	LigandsIBA 01/2021 - 04/2005
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2018 - 02/2013
4	Insulin-Like Growth Factor I (IGF-1)IBA 10/2007 - 05/2005
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2006 - 04/2005
3	Carcinoembryonic AntigenIBA 03/2024 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 03/2024 - 07/2005
3	AntibodiesIBA 01/2023 - 07/2014
3	AlbuminsIBA 01/2023 - 01/2018
3	Monoclonal AntibodiesIBA 02/2018 - 09/2005
3	trametinibIBA 01/2016 - 02/2013
3	ErbB Receptors (EGF Receptor)IBA 07/2014 - 01/2005
3	Phosphotransferases (Kinase)IBA 02/2013 - 01/2005
3	IGF Type 1 Receptor (IGF 1 Receptor)IBA 10/2007 - 09/2005
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 07/2006 - 05/2005
3	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2006 - 04/2005
2	Immunoconjugates (Immunoconjugate)IBA 03/2024 - 02/2018
2	Peptides (Polypeptides)IBA 03/2024 - 01/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2024 - 05/2005
2	Culture MediaIBA 01/2024 - 01/2021
2	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2023 - 12/2021
2	Hormones (Hormone)IBA 12/2023 - 12/2018
2	BilirubinIBA 01/2023 - 04/2020
2	Opioid Analgesics (Opioids)IBA 11/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2011
2	Tumor Biomarkers (Tumor Markers)IBA 08/2020 - 10/2018
2	Indicators and Reagents (Reagents)IBA 09/2019 - 03/2002
2	Lapatinib (GW572016)FDA Link 07/2014 - 02/2013
2	Capecitabine (Xeloda)FDA Link 01/2014 - 03/2011
2	tyrosine receptor (receptor, tyrosine)IBA 02/2013 - 07/2005
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2013 - 01/2005
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2008 - 08/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2008 - 04/2003
2	Coloring Agents (Dyes)IBA 09/2006 - 03/2002
2	Catalytic RNA (Ribozymes)IBA 07/2006 - 05/2005
2	Vascular Endothelial Growth Factor BIBA 01/2006 - 07/2005
2	Urokinase Plasminogen Activator ReceptorsIBA 09/2005 - 05/2005
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 09/2005 - 05/2005
2	Melphalan (Alkeran)FDA LinkGeneric 04/2003 - 08/2002
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 03/2024
1	Complementary DNA (cDNA)IBA 03/2024
1	Chimeric Antigen ReceptorsIBA 03/2024
1	Histones (Histone)IBA 03/2024
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2024
1	Histone DemethylasesIBA 03/2024
1	Histone MethyltransferasesIBA 03/2024
1	MelatoninIBA 12/2023
1	NF-kappa B (NF-kB)IBA 09/2023
1	pembrolizumabIBA 09/2023
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 01/2023
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2023
1	Adenosine A2B ReceptorIBA 01/2023
1	Adenosine (Adenocard)FDA LinkGeneric 01/2023
1	Adenosine Triphosphate (ATP)IBA 01/2023
1	TeaIBA 11/2022
1	Floxuridine (FUdR)FDA LinkGeneric 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	ChromatinIBA 01/2022

Therapy/Procedure

19	Therapeutics 03/2024 - 01/2005
19	Hepatectomy 02/2024 - 10/2012
11	Lymph Node Excision (Lymph Node Dissection) 01/2024 - 08/2009
8	Drug Therapy (Chemotherapy) 03/2024 - 01/2005
5	Adjuvant Chemotherapy 03/2023 - 10/2017
4	Neoadjuvant Therapy 09/2023 - 01/2014
4	Pancreaticoduodenectomy 11/2022 - 06/2015
3	Length of Stay 01/2024 - 01/2018
3	Pancreatectomy 11/2018 - 05/2011
2	Blood Transfusion (Blood Transfusions) 01/2024 - 01/2016
2	Radiofrequency Ablation 02/2019 - 11/2014
2	Immunotherapy 01/2018 - 01/2016
1	Operative Time 01/2024
1	Analgesia 11/2022